MicroRNAs as future therapeutic targets in COPD?

Ken R. Bracke, Pieter Mestdagh

Source: Eur Respir J, 49 (5) 1700431; 10.1183/13993003.00431-2017

Journal Issue: May

Disease area: Airway diseases

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Ken R. Bracke, Pieter Mestdagh. MicroRNAs as future therapeutic targets in COPD?. Eur Respir J, 49 (5) 1700431; 10.1183/13993003.00431-2017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

MicroRNAs in COPD: small molecules with big potential Source: Eur Respir J, 53 (4) 1900515; 10.1183/13993003.00515-2019 Year: 2019
Fibrocytes: potential new therapeutic targets for pulmonary hypertension? Source: Eur Respir J 2010; 36: 1232-1235 Year: 2010
Lots of promising targets and biomarkers, but how can we deliver the next generation of severe asthma trials? Source: International Congress 2019 – Beyond T2 mechanisms in asthma: who are the other players? Year: 2019
Pathophysiology and potential future therapeutic targets using preclinical models of COVID-19 Source: ERJ Open Res, 6 (4) 00405-2020; 10.1183/23120541.00405-2020 Year: 2020
What are the targets? Source: Respiratory Failure and Mechanical Ventilation Conference 2020 Year: 2020
Novel targets and emerging therapies in MPM Source: ERS Skills course: Multi-disciplinary care in thoracic oncology Year: 2019
Does acute and persistent metabolic dysregulation in COVID-19 point to novel biomarkers and future therapeutic strategies? Source: Eur Respir J, 59 (2) 2102417; 10.1183/13993003.02417-2021 Year: 2022
Can YKL-40 be used as a biomarker and therapeutic target for adult asthma? Source: Eur Respir J, 51 (1) 1702194; 10.1183/13993003.02194-2017 Year: 2018
Translational research approaches for finding new therapeutic targets involved in viral-induced asthma and COPD exacerbation Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014
MicroRNAs in the pathogenesis of pulmonary fibrosis Source: International Congress 2015 – PG8 Airway and lung fibrosis Year: 2015
Genetic studies as a tool for identifying novel potential targets for treatment of COPD Source: Eur Respir J, 50 (5) 1702042; 10.1183/13993003.02042-2017 Year: 2017
Th17 cytokines: novel potential therapeutic targets for COPD pathogenesis and exacerbations Source: Eur Respir J, 50 (4) 1602434; 10.1183/13993003.02434-2016 Year: 2017
MicroRNAs and pulmonary hypertension Source: Eur Respir J 2014; 43: 313-314 Year: 2004
Genes, mechanisms and new therapies for asthma Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung Year: 2010
COPD mechanisms: novel aspects and implications for new therapies Source: ERS Live 2007 Year: 2007